Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma-Reference-Cited by-同舟云学术

Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma

Published:2019-11-18 Issue:8 Volume:39 Page:1773-1783
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Chobrutskiy Boris I.,Yeagley Michelle,Tipping Price,Zaman Saif,Diviney Andrea,Patel Dhruv N.,Falasiri Shayan,Uversky Vladimir N.^ORCID,Blanck George^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-019-1101-2.pdf

Reference35 articles.

1. Berghoff AS, Kiesel B, Widhalm G, Wilhelm D, Rajky O, Kurscheid S, et al. Correlation of immune phenotype with IDH mutation in diffuse glioma. Neuro Oncol. 2017;19:1460–8.

2. Chobrutskiy BI, Zaman S, Tong WL, Diviney A, Blanck G. Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade. J Neurooncol. 2018;140:697–704.

3. Davidson TB, Lee AH, Hsu M, Sedighim S, Orpilla J, Treger J, et al. Expression of PD-1 by T cells in malignant glioma patients reflects exhaustion and activation. Clin Cancer Res: Off J Am Assoc Cancer Res. 2018;25:1913–22.

4. Han S, Zhang C, Li Q, Dong J, Liu Y, Huang Y, et al. Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma. Br J cancer. 2014;110:2560–8.

5. Cohen AL, Holmen SL, Colman H. IDH1 and IDH2 mutations in gliomas. Curr Neurol Neurosci Rep. 2013;13:345.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical complementarity of tumor resident, T-cell receptor CDR3s and renalase-1 correlates with increased melanoma survival;Oncotarget;2024-08-05

2. Chemical Complementarity of Tumor Resident, Adaptive Immune Receptor CDR3s and Previously Defined Hepatitis C Virus Epitopes Correlates with Improved Outcomes in Hepatocellular Carcinoma;Viral Immunology;2023-12-01

3. An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen;Oncoscience;2023-11-10

4. TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma;Cancer Biomarkers;2023-09-05

5. Exploiting big data survival information to unify risk-stratification related, adaptive immune receptor parameters for multiple myeloma;Genes & Immunity;2023-07-13